A. Spanevello (Tradate, Italy), P. Pignatti (Pavia, Italy), R. Louis (Liege, Belgium), D. Tarnoki (Budapest, Hungary)
LATE-BREAKING ABSTRACT: The effect of temperature during sputum processing on inflammatory markers
Q. Zhang, N. Li, M. He, M. Feng, J. Li (Guangzhou, China)
|   |
Comparison of exhaled nitric oxide values measured by two offline methods or NO breath
I. Jun, T. Takahiro, A. Ryo, W. Kentaro, M. Takashi, H. Hiroaki, S. Kiyoshi, O. Chiyako, T. Naomi, H. Norihiro, M. Akio, H. Maki, T. Masami, T. Kazuhisa, A. Kazuo (Sagamihara, Tokyo, Japan)
| |
Dialysis plus ultrafiltration significantly improves the detection of cytokines in induced sputum
C. Agache, B. Rückert, I. Agache, C. Ciobanu, C. Akdis (Davos, Switzerland; Brasov, Romania)
| |
Peak expiratory flow (PEF) as a predictive factor of elevated fraction exhaled nitric oxide (FENO) in young healthy swimmers in indoor chlorinated pools
S. Peletidou, G. Vavougios, S. Vasileios, E. Karetsi, K. Gourgoulianis, Z. Daniil (Larissa, Greece)
| |
Granule cytotoxic activity and oxidative DNA damage in smoking and non-smoking asthmatics
N. Soulitzis, A. Proklou, E. Neofytou, N. Rovina, E. Zervas, M. Gaga, E. Kallitsi, N. Siafakas, E. Tzortzaki (Heraklion, Athens, Greece)
| |
Activin –A and follistatin in sputum supernatant and BAL in patients with asthma
A. Papaporfyriou, P. Bakakos, K. Kostikas, G. Papatheodorou, G. Hillas, E. Konstantelou, N. Koulouris, S. Papiris, S. Loukides (Athens, Greece)
| |
Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients
D. Jash, A. Bandyopadhyay, P. Roy, K. Saha, D. Jash (Kolkata, India)
| |
A low sputum MMP-9 activity/TIMP ratio is associated with CT airway wall thickness in smokers with asthma
R. Chaudhuri, C. McSharry, J. Brady, C. Grierson, C. M. Messow, M. Spears, K. Nocka, W. MacNee, M. Connell, J. Murchison, M. Sproule, D. Miller, N. Thomson (Glasgow, Dundee, Edinburgh, United Kingdom; Cambridge MA & Collegeville, PA, United States Of America)
| |
Treating peripheral eosinophilia in asthma: Simple and effective
D. Yew, K. Su, R. Yadavilli, M. Murthy, H. Burhan (Liverpool, United Kingdom)
| |
Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease
O. Kar Kurt, M. Tosun, E. B. Kurt, F. Talay (Bolu, Turkey)
| |
Clara cells protein 16 (CC-16) level correlates with hemoglobin level in COPD patients
A. Nowinski, D. Korzybski, B. Bialas-Chromiec, D. Gorecka (Warsaw, Poland)
| |
Serum levels of a MMP-12 generated type IV collagen fragment is elevated in COPD and IPF patients
J. M. Sand, F. Genovese, F. Martinez, M. Han, C. Hogaboam, M. A. Karsdal, D. J. Leeming (Herlev, Denmark; Ann Arbor, United States Of America)
| |
Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
N. Khan, M. Daga, G. Mawari, S. A. Husain (New Delhi, India)
| |
Assessment of sputum prostaglandins and leukotrienes in COPD exacerbations
O. Drozdovszky, I. Barta, B. Antus (Budapest, Hungary)
| |
Sputum biomarkers of inflammation in smokers and subjects with COPD
J. Gao, H. Ilumets, A. Linja-aho, S. Ohlmeier, N. Ishikawa, H. Kobayashi, T. Toljamo, V. L. Kinnula, V. Pulkkinen, W. Mazur (Helsinki, Oulu, Rovaniemi, Finland; Hiroshima, Tokorozawa, Japan)
| |
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
L. C. Mutlu, M. Oran, S. Güzel, O. Avci, B. C. Yalçin, V. Küçükyalçin (Tekirdag, Turkey)
| |
Carnitine deficiency in chronic obstructive pulmonary disease patients
M. Suleman, A. Attia, M. Elsammak (Dammam, Saudi Arabia)
| |
Downregulation of IL-27 bronchial epithelial expression by heat-shock protein-60
D. Vallese, A. Pitruzzella, I. Gnemmi, F. Bucchieri, F. Cappello, B. Balbi, A. Di Stefano (Veruno, Palermo, Italy)
| |
Microarray profiling of COPD patients versus non-COPD smokers reveals possible disease biomarkers
D. Kampas, E. Neofytou, N. Soulitzis, D. Dermitzaki, N. Siafakas, E. Tzortzaki (Heraklion, Greece)
| |
Surfactant protein A in particles in exhaled air (PEx) – A better reflection of small airways in comparison to bronchoalveolar lavage and serum?
M. Lärstad, P. Larsson, A. C. Almstrand, E. Mirgorodskaya, G. C. Riise, A. C. Olin (Gothenburg, Sweden)
| |